A Peek into the Future – Repair and Replacement of the Mitral and Tricuspid Valves with the Edwards Portfolio: On-demand Programme
This on-demand version of the broadcast 'A Peek into the Future – Repair and Replacement of the Mitral and Tricuspid Valves with the Edwards Portfolio' comprises an internationally-respected faculty, as they review the PASCAL platform focusing on the recently CE mark approved PASCAL Ace implant system for the treatment of mitral and tricuspid regurgitation. Under the stewardship of programme Chair, Prof Nicolas van Mieghem, Erasmus Medical Center, Rotterdam, this programme examines the role of the PASCAL platform the the treatment of MR, the PASCAL Ace Implant System in the treatment of TR, valve replacement with EVOQUE, and includes a live procedure from Heidelberg University Hospital to best enhance practical learnings.
Pipeline products for tricuspid transcatheter replacement from Edwards Lifesciences will be shown and briefly discussed.
Learning objectives
- Outline the pathogenic nature and clinical risk of extended exposure to elevated LDL-C
- Describe the clinical challenges in achieving guideline-based LDL-C goals
- Compare and contrast LDL-C lowering therapies
Audience
- Interventional Cardiologists
- General Cardiologists
- Heart Failure Specialists
- Echocardiographers
- Nurses
More from this programme
Part 1
Introduction – A Peek into the Future Repair and Replacement of the Mitral & Tricuspid Valves With the Edwards Portfolio
Part 2
The PASCAL Platform – Successfully and Confidently Treat MR
Part 3
The PASCAL Ace Implant System – Therapy to Successfully Treat TR
Part 4
Looking into the Future – Valve Replacement with the EVOQUE
Part 5
Case – PASCAL Ace Implant System for the Treatment of TR
Faculty Biographies
Nicolas M Van Mieghem
Full Professor of Interventional Cardiology
Prof Van Mieghem initially intended to train as a cardiac surgeon but decided to specialise in interventional cardiology instead, following advice from a mentor. This decision was cemented when he read the first-in-human case report of transcatheter aortic valve implantation (TAVI) in Circulation by Alain Cribier in 2002. Prof Van Mieghem believes that great cardiologist genuinely cares for their patients. He names Gary Roubin, Dr Manu Malbrain and Professor Patrick Serruys among his mentors.
Academic History
Prof. Nicolas M. Van Mieghem completed his medical training at the Catholic University of Leuven (Belgium), where he earned both his medical degree and his specialist degree in cardiology. During his time in Leuven, he developed a strong interest in cardiovascular medicine, particularly in the emerging field of minimally invasive cardiac interventions. After finishing his core medical and cardiology training, he pursued multiple advanced…